Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryan B Corcoran

Showing results (71-80 of 106) with videos related to

Pageof 11
Sort By:
Biorxiv : the Preprint Server for Biology|October 10, 2024
A unique interplay of access and selection shapes peritoneal metastasis evolution in colorectal cancerEmma Ce Wassenaar, Alexander N Gorelick, Wei-Ting Hung, et al.
Nature Medicine|July 8, 2015
Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patientsGiulia Siravegna, Benedetta Mussolin, Michela Buscarino, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2019
Co-occurring Alterations in the RAS-MAPK Pathway Limit Response to MET Inhibitor Treatment in MET Exon 14 Skipping Mutation-Positive Lung CancerJulia K Rotow, Philippe Gui, Wei Wu, et al.
JCO Precision Oncology|July 12, 2021
Circulating Tumor DNA Predicts Pathologic and Clinical Outcomes Following Neoadjuvant Chemoradiation and Surgery for Patients With Locally Advanced Rectal CancerSusan G R McDuff, Karin M Hardiman, Peter J Ulintz, et al.
Cancer Discovery|February 13, 2018
Convergent Therapeutic Strategies to Overcome the Heterogeneity of Acquired Resistance in <i>BRAF</i><sup>V600E</sup> Colorectal CancerMehlika Hazar-Rethinam, Marianna Kleyman, G Celine Han, et al.
Nature Medicine|June 2, 2015
Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patientsGiulia Siravegna, Benedetta Mussolin, Michela Buscarino, et al.
Cancer|February 9, 2022
Cell-free human papillomavirus DNA kinetics after surgery for human papillomavirus-associated oropharyngeal cancerConnor J O'Boyle, Giulia Siravegna, Shohreh Varmeh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 31, 2021
Results and Molecular Correlates from a Pilot Study of Neoadjuvant Induction FOLFIRINOX Followed by Chemoradiation and Surgery for Gastroesophageal AdenocarcinomasJennifer Y Wo, Jeffrey W Clark, Christine E Eyler, et al.
Nature Biotechnology|February 12, 2020
Antibody-mediated delivery of viral epitopes to tumors harnesses CMV-specific T cells for cancer therapyDavid G Millar, Rakesh R Ramjiawan, Kosuke Kawaguchi, et al.
Cancer Discovery|February 13, 2015
Clinical Acquired Resistance to RAF Inhibitor Combinations in BRAF-Mutant Colorectal Cancer through MAPK Pathway AlterationsLeanne G Ahronian, Erin M Sennott, Eliezer M Van Allen, et al.
Pageof 11

Showing results (71-80 of 106) with videos related to

Sort By:
Pageof 11
Biorxiv : the Preprint Server for Biology|October 10, 2024
A unique interplay of access and selection shapes peritoneal metastasis evolution in colorectal cancerEmma Ce Wassenaar, Alexander N Gorelick, Wei-Ting Hung, et al.
Nature Medicine|July 8, 2015
Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patientsGiulia Siravegna, Benedetta Mussolin, Michela Buscarino, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2019
Co-occurring Alterations in the RAS-MAPK Pathway Limit Response to MET Inhibitor Treatment in MET Exon 14 Skipping Mutation-Positive Lung CancerJulia K Rotow, Philippe Gui, Wei Wu, et al.
JCO Precision Oncology|July 12, 2021
Circulating Tumor DNA Predicts Pathologic and Clinical Outcomes Following Neoadjuvant Chemoradiation and Surgery for Patients With Locally Advanced Rectal CancerSusan G R McDuff, Karin M Hardiman, Peter J Ulintz, et al.
Cancer Discovery|February 13, 2018
Convergent Therapeutic Strategies to Overcome the Heterogeneity of Acquired Resistance in <i>BRAF</i><sup>V600E</sup> Colorectal CancerMehlika Hazar-Rethinam, Marianna Kleyman, G Celine Han, et al.
Nature Medicine|June 2, 2015
Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patientsGiulia Siravegna, Benedetta Mussolin, Michela Buscarino, et al.
Cancer|February 9, 2022
Cell-free human papillomavirus DNA kinetics after surgery for human papillomavirus-associated oropharyngeal cancerConnor J O'Boyle, Giulia Siravegna, Shohreh Varmeh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 31, 2021
Results and Molecular Correlates from a Pilot Study of Neoadjuvant Induction FOLFIRINOX Followed by Chemoradiation and Surgery for Gastroesophageal AdenocarcinomasJennifer Y Wo, Jeffrey W Clark, Christine E Eyler, et al.
Nature Biotechnology|February 12, 2020
Antibody-mediated delivery of viral epitopes to tumors harnesses CMV-specific T cells for cancer therapyDavid G Millar, Rakesh R Ramjiawan, Kosuke Kawaguchi, et al.
Cancer Discovery|February 13, 2015
Clinical Acquired Resistance to RAF Inhibitor Combinations in BRAF-Mutant Colorectal Cancer through MAPK Pathway AlterationsLeanne G Ahronian, Erin M Sennott, Eliezer M Van Allen, et al.
Pageof 11